These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Infant Dextromethorphan and Dextrorphan Exposure via Breast Milk From Mothers Who Are CYP2D6 Extensive Metabolizers. Shum S, Yadav A, Fay E, Moreni S, Mao J, Czuba L, Wang C, Isoherranen N, Hebert MF. J Clin Pharmacol; 2022 Jun; 62(6):747-755. PubMed ID: 34889461 [Abstract] [Full Text] [Related]
5. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan. Lauterbach EC. Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777 [Abstract] [Full Text] [Related]
11. Alternative methods for CYP2D6 phenotyping: comparison of dextromethorphan metabolic ratios from AUC, single point plasma, and urine. Chen R, Wang H, Shi J, Hu P. Int J Clin Pharmacol Ther; 2016 May; 54(5):330-6. PubMed ID: 26902503 [Abstract] [Full Text] [Related]
12. Effect of metabolic blockade on the psychoactive effects of dextromethorphan. Zawertailo LA, Tyndale RF, Busto U, Sellers EM. Hum Psychopharmacol; 2010 Jan; 25(1):71-9. PubMed ID: 20041473 [Abstract] [Full Text] [Related]
13. Dextromethorphan and dextrorphan in rats: common antitussives--different behavioural profiles. Dematteis M, Lallement G, Mallaret M. Fundam Clin Pharmacol; 1998 Jan; 12(5):526-37. PubMed ID: 9794151 [Abstract] [Full Text] [Related]